Tumor-selective angiotensin blockers may improve response to cancer immunotherapy
A research team led by investigators at Massachusetts General Hospital (MGH) and the Massachusetts Institute of Technology (MIT) has found that combining a specialized version of an antihypertension drug with immune checkpoint ...
Apr 29, 2019
0
112